CD271 on melanoma cell is an IFN-γ-inducible immunosuppressive factor that mediates downregulation of melanoma antigens

Journal of Investigative Dermatology

Volumn 134, Issue 5, 2014, Pages 1369-1377

  Furuta, Junpei ^a   Inozume, Takashi ^a   Harada, Kazutoshi ^a   Shimada, Shinji ^a  

^a UNIVERSITY OF YAMANASHI   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPALENE; COMPLEMENTARY DNA; GAMMA INTERFERON; HLA A ANTIGEN; MELANOMA ANTIGEN; MICROPHTHALMIA ASSOCIATED TRANSCRIPTION FACTOR; NEUROTROPHIN RECEPTOR P75; PROGRAMMED DEATH 1 LIGAND 1; TUMOR NECROSIS FACTOR ALPHA; APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3G; BONE MORPHOGENETIC PROTEIN 6; CALCEIN; CD271 ANTIGEN; HLA DPB1 ANTIGEN; HLA DQA1 ANTIGEN; HLA DRB1 ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON CONSENSUS SEQUENCE BINDING PROTEIN; MELAN A; NERVE GROWTH FACTOR; NEUROTROPHIN RECEPTOR; PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE; PROTEIN P75; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DOWN REGULATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IN VITRO STUDY; MELANOMA CELL; MICROARRAY ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; CANCER STEM CELL; GENE EXPRESSION; MELANOMA; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANTIGENS, CD274; CELL LINE, TUMOR; DOWN-REGULATION; HUMANS; IMMUNE TOLERANCE; INTERFERON-GAMMA; MART-1 ANTIGEN; MELANOMA; MELANOMA-SPECIFIC ANTIGENS; NERVE TISSUE PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RECEPTORS, NERVE GROWTH FACTOR; SKIN NEOPLASMS; T-LYMPHOCYTES, CYTOTOXIC; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 84900847606     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2013.490     Document Type: Article

References (17)

1. Ahmadzadeh M, Johnson LA, Heemskerk B et al. (2009) Tumor antigenspecific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired. Blood 114:1537-44
2. Boiko AD, Razorenova OV, van de Rijn M et al. (2010) Human melanomainitiating cells express neural crest nerve growth factor receptor CD271. Nature 466:133-7
3. Brahmer JR, Tykodi SS, Chow LQ et al. (2012) Safety and activity of anti-PD-L1 antibody in patients with advanced cancer. N Engl J Med 366:2455-65
4. Dong H, Strome SE, Salomao DR et al. (2002) Tumor-Associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion. Nat Med 8:793-800
5. Dudley ME, Wunderlich JR, Robbins PF et al. (2002) Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes. Science 298:850-4
6. Hino R, Kabashima K, Kato Y et al. (2010) Tumor cell expression of programmed cell death-1 ligand 1 is a prognostic factor for malignant melanoma. Cancer 116:1757-66
7. Inozume T, Hanada K, Wang QJ et al. (2010) Selection of CD8+PD-1+ lymphocytes in fresh human melanomas enriches for tumor-reactive T cells. J Immunother 33:956-64
8. Johnson LA, Morgan RA, Dudley ME et al. (2009) Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen. Blood 114:535-46
9. Keir ME, Butte MJ, Freeman GJ et al. (2008) PD-1 and its ligands in tolerance and immunity. Annu Rev Immunol 26:677-704
10. Landsberg J, Kohlmeyer J, Renn M et al. (2012) Melanomas resist T-cell therapy through inflammation-induced reversible dedifferentiation. Nature 490:412-6
11. Micera A, Lambiase A, Stampachiacchiere B et al. (2007) Nerve growth factor and tissue repair remodeling: TrkA(NGFR) and p75(NTR), two receptors one fate. Cytokine Growth Factor Rev 18:245-56
12. Okamoto T, Inozume T, Mitsui H et al. (2010) Overexpression of GRIM-19 in cancer cells suppresses STAT3-mediated signal transduction and cancer growth. Mol Cancer Ther 9:2333-43
13. Palmer DC, Chan CC, Gattinoni L et al. (2008) Effective tumor treatment targeting a melanoma/melanocyte-Associated antigen triggers severe ocular autoimmunity. Proc Natl Acad Sci USA 105:8061-6
14. Shibagaki N, Udey MC (2002) Dendritic cells transduced with protein antigens induce cytotoxic lymphocytes and elicit antitumor immunity. J Immunol 168:2393-401
15. Topalian SL, Hodi FS, Brahmer JR et al. (2012) Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. N Engl J Med 366:2443-54
16. Wang QJ, Hanada K, Perry-Lalley D et al. (2005) Generating renal cancerreactive T cells using dendritic cells (DCs) to present autologous tumor. J Immunother 28:551-9
17. Zaidi MR, Merlino G (2011) The two faces of interferon-gamma in cancer. Clin Cancer Res 17:6118-24